RenJi Hospital: Carcinoma trials

The registry lists 31 Carcinoma studies with RenJi Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 8Phase 3 4No phase 20(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FGF19 Overexpression Combination Unified Study in HCC-19RecruitingNCT06978933Phase 2
• A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCCNot yet recruitingNCT06870279Phase 1
• Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell CarcinomaNot yet recruitingNCT06279403Phase 2
• Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy DataNot yet recruitingNCT06252974
• Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyRecruitingNCT06204406
• GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular CarcinomaRecruitingNCT05926726Not applicable
• Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )RecruitingNCT04443322Not applicable
• Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor ThrombusNot yet recruitingNCT04319484Phase 2/3
• NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCCActive, not recruitingNCT06762158Not applicable
• A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell CarcinomaCompletedNCT06656039
• Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell CarcinomaStatus unknownNCT05816642Not applicable
• IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver TransplantationStatus unknownNCT05339581Not applicable
• Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCCStatus unknownNCT04759235
• Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial CarcinomaCompletedNCT04672330Phase 2
• Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial CarcinomaStatus unknownNCT04672317Phase 2
• Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular CarcinomaCompletedNCT04642547Not applicable
• Effects of Anesthetic Methods on Hepatic Cancer Cell Function in VitroCompletedNCT04510935Not applicable
• Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC RecurrenceStatus unknownNCT04506398
• Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver TransplantStatus unknownNCT04425226Not applicable
• Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT04237740Phase 3
• Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular CarcinomaStatus unknownNCT04168944Phase 2/3
• Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell CarcinomaCompletedNCT04118855Phase 2
• Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell CarcinomaStatus unknownNCT03734614
• Effects of Anesthetic Methods on Hepatic Cancer Cell MalignancyCompletedNCT03594188Not applicable
• Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial CarcinomaStatus unknownNCT03544437
• Prognostic Value of Lymph Node Dissection in Patients With Transitional Cell Carcinoma of the Upper Urinary TractStatus unknownNCT03474926Phase 2
• CAR-GPC3 T Cells in Patients With Refractory Hepatocellular CarcinomaCompletedNCT03146234Not applicable
• Minocycline Attenuate Postoperative Cognitive Dysfunction and DeliriumStatus unknownNCT02928692Phase 3
• Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageStatus unknownNCT02924597Not applicable
• Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell CarcinomaCompletedNCT02326558Not applicable
• Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageStatus unknownNCT01838720Not applicable